← Leaderboards
Rajani Ravi
Johns Hopkins University
$840,375
Attributed
$1,680,750
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $336.1K · FY2014–18$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,680,750 · 1
By mechanism
R01$1,680,750 · 1
Top collaborators
- Atul Bedi5 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Paul F Worley$57,319,879
- Christopher A Ross$35,771,871
- Ted M. Dawson$31,695,689
- Steven R Kleeberger$929,417
- William Ramses Bishai$43,237,711
Others in their field
Top investigators on “Erbb2 Gene”
- Norman Wolmark · Nsabp Foundation, Inc.$43,988,954
- Charles M Perou · Univ Of North Carolina Chapel Hill$10,910,346
- Ellen M Velie · Michigan State University$10,395,017
- Leslie Bernstein · University Of Southern California$10,393,428
- Lewis A Chodosh · University Of Pennsylvania$10,338,684
- Carlos L Arteaga · Vanderbilt University$9,797,101
Research focus
Erbb2 GeneAdvanced DevelopmentEpithelialEpidermal Growth Factor ReceptorAntibodiesAntibody -Dependent Cell CytotoxicityDesignBalb/C Nude MouseCytotoxic T-Lymphocyte-Associated Protein 4Effector CellBreast Cancer TreatmentCd28 GeneCd34 GeneCd4 Positive T LymphocytesAttenuatedCytotoxicCellsCessation Of LifeCetuximabBispecific AntibodiesComparative EfficacyCtla4 GeneCytokineExhibits
Grant awards (5)
Bifunctional Immunostimulatory Antibodies for Treatment of Breast Cancer$336,150
R01 · FY2018 · CA
Bifunctional Immunostimulatory Antibodies for Treatment of Breast Cancer$336,150
R01 · FY2017 · CA
Bifunctional Immunostimulatory Antibodies for Treatment of Breast Cancer$336,150
R01 · FY2016 · CA
Bifunctional Immunostimulatory Antibodies for Treatment of Breast Cancer$336,150
R01 · FY2015 · CA
Bifunctional Immunostimulatory Antibodies for Treatment of Breast Cancer$336,150
R01 · FY2014 · CA